查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
無細胞RNA分離和提取試劑盒市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按應用、最終用戶、公司和地區細分
市場調查報告書
商品編碼
1321037

無細胞RNA分離和提取試劑盒市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按應用、最終用戶、公司和地區細分

Cell Free RNA Isolation & Extraction Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application, By End User, By Company, and By Region
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球無細胞 RNA 分離和提取試劑盒市場在2023-2027年預測期內將出現令人印象深刻的成長。主要因素包括不同類型癌症發病率的上升和產前併發症病例的增加，這些都促進了市場的成長。無細胞 RNA 分離和提取試劑盒市場是一個成熟的市場，是醫療決策不可或缺的一部分，有助於獲取廣泛治療傳播的資訊，強調其在醫療保健中的重要性。支持市場成長的其他因素包括老年人口基數的增加、廣泛的研究和開發、患者群體對無創和微創方法的認知、政府投資的增加以及技術的進步。此外，生物技術和製藥公司的戰略夥伴關係和合作推動市場的成長。

癌症發病率增加

人口中肺癌、子宮頸癌、乳腺癌等癌症的發病率不斷增加，是市場成長的一個因素。癌症是全球死亡和殘疾的第二大原因。無細胞RNA存在於無細胞液體中，是在腫瘤脫落率較低的患者中檢測腫瘤的機會。例如，2020年，國際癌症研究機構（IARC）發布的資料顯示，全球每5人中有1人在一生中罹患癌症，每8名男性和11名女性中有1名死於癌症。根據其修訂後的 GLOBOCAN2020 報告，全球登記了大約 1,930 萬個新癌症病例，1,000 萬人死於癌症。因此，癌症患者數量的增加促進了無細胞 RNA 分離和提取試劑盒市場的成長。

產前併發症病例數量不斷增加

過去幾年，無創技術（例如有助於預測產前併發症的無細胞RNA）的應用取得了快速進展。胎兒宮內生長受限 (IUGR)、子癎前症和自發性早產 (PTB) 等產前併發症可以透過無細胞 RNA (cf RNA) 進行表徵和預測。例如，2014年至2018年間，妊娠併發症發生率上升超過16%，而分娩併發症發生率上升超過14%。每1,000 名孕婦中約有7 人患有妊娠糖尿病和子癎前症併發症，自2014年以來增加了近31%。因此，由於患有產前併發症的婦女人數增加，對無細胞RNA 分離和治療的需求激增推動提取套件市場的成長。

市場細分

全球無細胞 RNA 分離和提取試劑盒市場分為應用程式、最終用戶和公司。根據應用，市場分為腫瘤學、產前篩查、代謝紊亂等。根據最終用戶，市場分為醫院和診所、製藥和生物技術公司等。就國家而言，由於美國癌症患病率不斷上升，預計在預測期內美國將成為一個利潤豐厚的市場。

市場參與者

F.Hoffmann-La Roche AG、JBS Science Inc.、Aline Biosciences、Apostle Inc. (Apostle Sciences)、Danagen-Bioted, SL、Norgen Biotek Corp.、PerkinElmer, Inc.、Promega Corporation、QIAGEN NV 和 Thermo Fisher Scientific Inc . 是市場上營運的一些領先公司。

可用的客製化

根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。本報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球無細胞 RNA 分離和提取試劑盒市場的影響

第5章：客戶之聲

第6章：全球無細胞 RNA 分離和提取試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按應用（腫瘤學、產前篩查、代謝紊亂、其他）
    • 按最終用戶（醫院和診所、製藥和生物技術公司、其他）
    • 按公司分類 (2021)
    • 按地區
  • 市場地圖

第7章：北美無細胞 RNA 分離和提取試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第8章：歐洲無細胞 RNA 分離和提取試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章：亞太地區無細胞 RNA 分離和提取試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第10章：南美無細胞 RNA 分離和提取試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲無細胞 RNA 分離和提取試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非無細胞 RNA 分離和提取試劑盒
    • 沙烏地阿拉伯無細胞 RNA 分離和提取試劑盒
    • UAE 無細胞 RNA 分離和提取試劑盒
    • 土耳其無細胞 RNA 分離和提取試劑盒
    • 埃及 無細胞 RNA 分離和提取試劑盒

第12章：市場動態

  • 促進因素
  • 挑戰

第13章：市場趨勢與發展

第14章：競爭格局

  • F.Hoffmann-La Roche AG
  • JBS Science Inc.
  • Aline Biosciences
  • Apostle Inc. (Apostle Sciences)
  • Danagen-Bioted, S.L.
  • Norgen Biotek Corp.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.

第15章：戰略建議

簡介目錄
Product Code: 12993

The global cell-free RNA isolation & extraction kits market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rising incidences of different types of cancer and a growing number of cases of prenatal complications, which are bolstering the growth of the market. The cell-free RNA isolation and extraction kits market is a well-established market with an integral part of medical decision-making, which aids in obtaining information for a wide range of treatment dissemination, emphasizing their cruciality in healthcare. The other factors supporting the market's growth are the rising geriatric population base, extensive research, and development, awareness among the patient population about non-invasive and minimally invasive methods, increasing government investments, and technological advancements. Also, strategic partnerships and collaborations by biotechnology and pharmaceutical companies are fueling the growth of the market.

Increasing Incidence of Cancer

The growing occurrences of cancer, such as lung cancer, cervical cancer, breast cancer, and others among the population, is a contributing factor to the growth of the market. Cancer is considered the second largest cause of mortality and disability across the globe. Cell-free RNA occurs in cell-free fluids and is an opportunity to detect tumors in patients with lower tumor-shedding rates. For instance, in 2020, data was released by the International Agency for Research on Cancer (IARC), which revealed that 1 in 5 people develop cancer in their lifetime, and 1 in 8 men and 1 in 11 women die from cancer globally. As per its revised GLOBOCAN 2020 report, roughly 19.3 million new cancer cases were registered, and 10 million people died from it across the globe. Thus, the increase in the number of patients suffering from cancer is bolstering the growth of the Cell-Free RNA Isolation & Extraction Kits Market.

Increasing Number of Cases with Prenatal Complications

Over the past few years, rapid advancements have been made in the application of non-invasive techniques such as cell-free RNA, which helps to predict prenatal complications. Prenatal complications such as intrauterine growth restriction (IUGR), preeclampsia, and spontaneous preterm birth (PTB) can be characterized and predicted by cell-free RNA (cf RNA). For instance, between 2014-2018, the pregnancy complications rates rose more than 16%, while childbirth complications rates rose more than 14%. Around seven out of every 1,000 pregnant women underwent gestational diabetes and preeclampsia complications, an almost 31% increase since 2014. Therefore, owing to the increase in the number of women suffering from prenatal complications, the surge in demand for cell-free RNA isolation and extraction kits is fueling the growth of the market.

Market Segmentation

The global cell-free RNA isolation & extraction kits market is segmented into application, end user, and company. Based on application, the market is divided into oncology, prenatal screening, metabolic disorders, and others. Based on end users, the market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising prevalence of cancer in the country.

Market Players

F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global cell-free RNA isolation & extraction kits market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cell Free RNA Isolation & Extraction Kits Market, By Application:

  • Oncology
  • Prenatal Screening
  • Metabolic Disorders
  • Others

Cell Free RNA Isolation & Extraction Kits Market, By End User:

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

Cell Free RNA Isolation & Extraction Kits Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in cell free RNA isolation & extraction kits market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Cell Free RNA Isolation & Extraction Kits Market

5. Voice of Customer

6. Global Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application (Oncology, Prenatal Screening, Metabolic Disorders, Others)
    • 6.2.2. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
    • 6.2.3. By Company (2021)
    • 6.2.4. By Region
  • 6.3. Market Map

7. North America Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End User
    • 7.3.2. Canada Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End User
    • 7.3.3. Mexico Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End User

8. Europe Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End User
    • 8.3.2. Germany Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End User
    • 8.3.3. United Kingdom Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End User
    • 8.3.4. Italy Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End User
    • 8.3.5. Spain Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End User

9. Asia-Pacific Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End User
    • 9.3.2. India Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End User
    • 9.3.3. Japan Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End User
    • 9.3.4. South Korea Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Application
        • 9.3.4.2.2. By End User
    • 9.3.5. Australia Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Application
        • 9.3.5.2.2. By End User

10. South America Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End User
    • 10.3.2. Argentina Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End User
    • 10.3.3. Colombia Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End User

11. Middle East and Africa Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Application
    • 11.2.2. By End User
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Application
        • 11.3.1.2.2. By End User
    • 11.3.2. Saudi Arabia Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Application
        • 11.3.2.2.2. By End User
    • 11.3.3. UAE Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Application
        • 11.3.3.2.2. By End User
    • 11.3.4. Turkey Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Application
        • 11.3.4.2.2. By End User
    • 11.3.5. Egypt Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Application
        • 11.3.5.2.2. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. F.Hoffmann-La Roche AG
  • 14.2. JBS Science Inc.
  • 14.3. Aline Biosciences
  • 14.4. Apostle Inc. (Apostle Sciences)
  • 14.5. Danagen-Bioted, S.L.
  • 14.6. Norgen Biotek Corp.
  • 14.7. PerkinElmer, Inc.
  • 14.8. Promega Corporation
  • 14.9. QIAGEN N.V.
  • 14.10. Thermo Fisher Scientific Inc.

15. Strategic Recommendations